Unproven stem cell interventions: A global public health problem requiring global deliberation

Simple item page
dc.contributor.authorMaster, Zubin
dc.contributor.authorMatthews, Kirstin R.W.
dc.contributor.authorAbou-el-Enein, Mohamed
dc.contributor.orgJames A. Baker III Institute for Public Policy
dc.date.accessioned2023-04-05T16:04:52Z
dc.date.available2023-04-05T16:04:52Z
dc.description.abstractThe unproven stem cell intervention (SCI) industry is a global health problem. Despite efforts of some nations, the industry continues to flourish. In this paper, we call for a global approach and the establishment of a World Health Organization (WHO) Expert Advisory Committee on Regenerative Medicine to tackle this issue and provide guidance. The WHO committee can harmonize national regulations; promote regulatory approaches responsive to unmet patient needs; and formulate an education campaign against misinformation. Fostering an international dialog and developing recommendations that can be adopted by member states would effectively address the global market of unproven SCIs.
dc.identifier.citationMaster, Zubin, Matthews, Kirstin R.W. and Abou-el-Enein, Mohamed. "Unproven stem cell interventions: A global public health problem requiring global deliberation." <i>Stem Cell Reports,</i> 16, no. 6 (2021) Cell Press: 1435-1445. https://doi.org/10.1016/j.stemcr.2021.05.004.
dc.identifier.digital1-s2-0-S2213671121002551-main
dc.identifier.urihttps://hdl.handle.net/1911/114546
dc.titleUnproven stem cell interventions: A global public health problem requiring global deliberation
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
1-s2-0-S2213671121002551-main.pdf
Size:
758.26 KB
Format:
Adobe Portable Document Format
Download
Collections
Baker Institute Publications